2018
DOI: 10.15419/bmrat.v5i12.509
|View full text |Cite
|
Sign up to set email alerts
|

The role of brain natriuretic peptides as a marker for diagnosing cardiac syncope: A narrative review

Abstract: Cardiac disease is the second common cause of syncope in emergency departments. Patients with Cardiac syncope have a higher risk of mortality than those who have a non-cardiac problem. Brain natriuretic peptide (BNP) as a cardiac marker has not thoroughly been evaluated in patients with syncope. This article focuses on the studies that have assessed BNP and NT-pro-BNP in cardiac and non-cardiac syncope patients in emergency departments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…N-terminal pro b-type natriuretic peptide (NT-proBNP) levels measured after an MI are related to the occurrence of cardiac adverse events within one year and can be used as a predictor of cardiac syncope after an MI, and may help to predict who are those patients at risk for SCD after an MI [34,35].…”
Section: Non-arrhythmia Mortality Risk Prediction Indicatorsmentioning
confidence: 99%
“…N-terminal pro b-type natriuretic peptide (NT-proBNP) levels measured after an MI are related to the occurrence of cardiac adverse events within one year and can be used as a predictor of cardiac syncope after an MI, and may help to predict who are those patients at risk for SCD after an MI [34,35].…”
Section: Non-arrhythmia Mortality Risk Prediction Indicatorsmentioning
confidence: 99%